Lancet 2 (7349), 2021
Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, Janus C, Blond MB, Rosenkilde M, Bogh AF, Gliemann L, Jensen JB, Antoniades C, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS
GLP-1 helps to regulate blood sugar
Published clinical trials have reported substantial average body weight reductions over structured trial windows, which is why retatrutide is frequently referenced in modern metabolic research discussions
Giving the GLP-1 analogue ROSE-010 to a mixed group of IBS patients decreased GI motility and relieved acute discomfort, according to a placebo-controlled double-blind crossover clinical experiment (24)
Other policies like 340B have failed to deliver meaningful savings